125 related articles for article (PubMed ID: 19322947)
1. Hodgkin lymphoma and the impact of age.
Armitage JO
Oncology (Williston Park); 2008 Nov; 22(12):1379, 1385. PubMed ID: 19322947
[No Abstract] [Full Text] [Related]
2. Hodgkin lymphoma in the elderly: a clinical review of treatment and outcome, past, present and future.
Proctor SJ; Wilkinson J; Sieniawski M
Crit Rev Oncol Hematol; 2009 Sep; 71(3):222-32. PubMed ID: 19179093
[TBL] [Abstract][Full Text] [Related]
3. XII. Hodgkin lymphoma in older patients: challenges and opportunities to improve outcomes.
Jagadeesh D; Diefenbach C; Evens AM
Hematol Oncol; 2013 Jun; 31 Suppl 1():69-75. PubMed ID: 23775654
[No Abstract] [Full Text] [Related]
4. Treatment of Hodgkin lymphoma: a 50-year perspective.
Canellos GP; Rosenberg SA; Friedberg JW; Lister TA; Devita VT
J Clin Oncol; 2014 Jan; 32(3):163-8. PubMed ID: 24441526
[No Abstract] [Full Text] [Related]
5. The challenges of Hodgkin lymphoma in the elderly.
Coiffier B
Oncology (Williston Park); 2008 Nov; 22(12):1388, 1393. PubMed ID: 19322948
[No Abstract] [Full Text] [Related]
6. Hodgkin's disease and other human malignant lymphomas: advances and prospects--G.H.A. Clowes Memorial Lecture.
Kaplan HS
Cancer Res; 1976 Nov; 36(11 Pt 1):3863-78. PubMed ID: 788894
[No Abstract] [Full Text] [Related]
7. [Malignant lymphoma in children].
Leverger G; Frappaz D; Patte C; Philip T
Rev Prat; 1993 Nov; 43(17):2177-81. PubMed ID: 8146532
[TBL] [Abstract][Full Text] [Related]
8. [Fundamental approaches to the treatment of refractory and relapsed Hodgkin lymphoma].
Filatova LV; Tarasenkova AA; Semiglazova TIu; Gershanovich ML
Vopr Onkol; 2012; 58(4):443-53. PubMed ID: 23607197
[No Abstract] [Full Text] [Related]
9. XVII. Treatment of advanced-stage Hodgkin lymphoma.
Engert A
Hematol Oncol; 2015 Jun; 33 Suppl 1():87-9. PubMed ID: 26062063
[No Abstract] [Full Text] [Related]
10. [Diagnosis and treatment of nodular lymphocyte predominant Hodgkin lymphoma].
Nagai H
Nihon Rinsho; 2012 Apr; 70 Suppl 2():561-7. PubMed ID: 23134016
[No Abstract] [Full Text] [Related]
11. Nodular lymphocyte predominant Hodgkin lymphoma with non-invasive or early invasive growth pattern suggests an early step of the disease with a highly favorable outcome.
Carbone A; Spina M; Gloghini A; Ponzoni M; Doglioni C; Tirelli U
Am J Hematol; 2013 Feb; 88(2):161-2. PubMed ID: 23349009
[No Abstract] [Full Text] [Related]
12. Intracerebral progression of Hodgkin lymphoma in a man with HIV.
Saloura V; Grivas PD; Mapow D; Kazmi K; Ward K; Styler M
Postgrad Med; 2009 Nov; 121(6):170-5. PubMed ID: 19940428
[TBL] [Abstract][Full Text] [Related]
13. Hodgkin disease relapse discovered at the time of liver transplant for acute liver failure.
Hope BC; Chau KY; Evans HM; Mouat S; Munn S; Yeong ML; Chin SE
Pediatr Transplant; 2012 Feb; 16(1):E10-4. PubMed ID: 21054714
[TBL] [Abstract][Full Text] [Related]
14. [Hodgkin's lymphoma studies in pediatrics--an example of efficiency and cooperation].
Lampert F
Klin Padiatr; 1986; 198(3):135-6. PubMed ID: 3523019
[No Abstract] [Full Text] [Related]
15. Modern management of lymphocyte-predominant Hodgkin lymphoma.
Xing KH; Savage KJ
Br J Haematol; 2013 May; 161(3):316-29. PubMed ID: 23398605
[TBL] [Abstract][Full Text] [Related]
16. I. Hodgkin lymphoma: special challenges and solutions.
Connors JM
Hematol Oncol; 2015 Jun; 33 Suppl 1():21-4. PubMed ID: 26062048
[No Abstract] [Full Text] [Related]
17. [Hodgkin lymphoma and non-Hodgkin lymphoma].
Yamaguchi M
Rinsho Ketsueki; 2013 Jan; 54(1):81-8. PubMed ID: 23391651
[No Abstract] [Full Text] [Related]
18. Why are patients with malignant lymphomas excluded from clinical trials? The experience of an oncology institute in Italy.
Serraino D; Zagonel V; Bordonaro R; Franceschi S
Eur J Cancer; 1998 Feb; 34(3):427-8. PubMed ID: 9640236
[No Abstract] [Full Text] [Related]
19. Classical Hodgkin lymphoma, lymphocyte depleted type: clinicopathological analysis and prognostic comparison with other types of classical Hodgkin lymphoma.
Karube K; Niino D; Kimura Y; Ohshima K
Pathol Res Pract; 2013 Apr; 209(4):201-7. PubMed ID: 23478005
[TBL] [Abstract][Full Text] [Related]
20. The treatment of childhood Hodgkin lymphoma: improved survival in a developing country.
Büyükpamukçu M; Varan A; Akyüz C; Atahan L; Ozyar E; Kale G; Köksal Y; Kutluk T
Acta Oncol; 2009; 48(1):44-51. PubMed ID: 18777215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
